Epoch Biodesign, a UK-based biotech startup, has secured $18.3 million in Series A funding to scale up production of its plastic-eating enzymes, aiming to disrupt the plastic pollution cycle.
Colossal's CEO Ben Lamm clarifies the company's goals, ruling out a Jurassic Park scenario, and outlines ambitious plans for de-extinction and conservation.
Genetics testing company 23andMe files for Chapter 11 bankruptcy protection to initiate asset sale, CEO Anne Wojcicki to bid on company as independent buyer
DNA testing service 23andMe files for bankruptcy, prompting users to take action to protect their genetic data from potential misuse by new owners.
Copyright © 2024 Starfolk. All rights reserved.